Home/ Supplements/ Vitamin A/ Vitality Women

Vitality Women

product on market Tablet or Pill Melaleuca Safety: 99/100
99/100

This product looks safe

  • Niacin: 75mg is 2.1× the Tolerable Upper Intake Level (35mg)
  • 71% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains a blend of fat-soluble and antioxidant vitamins known to support immune function and cellular health. Research provides strong evidence for the roles of vitamins A, C, D3, E, and K in maintaining systemic wellness. The ingredient profile is associated with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 75mg is 2.1× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Vitality Women
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
71%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
3000 IU (60% DV)
Vitamin C
150 mg (250% DV)
200 IU (50% DV)
Within RDA (0.3× RDA) 608 studies (A:16, B:251)
30 IU (100% DV)
1.3× RDA — within safe limits 179 studies (A:3, B:90)
28 mcg (35% DV)
Within RDA (0.2× RDA) 275 studies (A:9, B:175)
15 mg (1000% DV)
12.5× RDA — above typical dose 76 studies (A:0, B:33)
17 mg (1000% DV)
13.1× RDA — above typical dose 13 studies (A:0, B:1)
75 mg (375% DV)
Exceeds UL by 2.1× (UL: 35 mg) 196 studies (A:5, B:63)
10 mg (500% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
800 mcg (200% DV)
2.0× RDA — within safe limits 226 studies (A:10, B:105)
12 mcg (200% DV)
5.0× RDA — above typical dose 139 studies (A:1, B:44)
300 mcg (100% DV)
10.0× RDA — above typical dose 27 studies (A:0, B:11)
20 mg (200% DV)
4.0× RDA — above typical dose 2 studies — no high-quality reviews
250 mg (25% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Iron
9 mg (50% DV)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
200 mg (50% DV)
Within RDA (0.5× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
105 mcg (150% DV)
1.9× RDA — within safe limits 173 studies (A:0, B:67)
3 mg (150% DV)
3.3× RDA — above typical dose (UL: 10 mg) 37 studies (A:0, B:11)
2.5 mg (125% DV)
1.1× RDA — within safe limits 9 studies — no high-quality reviews
120 mcg (100% DV)
3.4× RDA — above typical dose 199 studies (A:1, B:55)
75 mcg (100% DV)
1.7× RDA — within safe limits 3 studies — no high-quality reviews
150 mcg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Hydroxypropyl Methylcellulose Silicon Dioxide Magnesium Stearate Hydroxypropyl Cellulose Polyethylene Glycol Stearic Acid Vanillin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

Directions: Take two tablets per day, preferably with food.

Warnings & Precautions

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.

Formulation Notes

Oligo

Gluten-free

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.

Additional Information

Multivitamin & Mineral

Metadata

Product Details

DSLD Entry Date2019-11-21
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
DSLD ID208852
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.